FIELD: medicine.
SUBSTANCE: the present innovation deals with applying transdermal therapeutic system (TTS) with fentanyl of fentanyl-similar derivatives as an active substance. For avoiding random (incorrect) overdosing due to uncontrolled release of active substance being the result of a lesion, the active substance is in microreservoirs full of liquid. If necessary, the layer with active substance can be supplied with a membrane. The system in question favors steady release of active substance.
EFFECT: higher efficiency.
13 cl, 4 dwg, 6 ex, 6 tbl
Authors
Dates
2007-12-10—Published
2002-07-10—Filed